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Introduction
Cell death and apoptosis
The number of cells in a population is regulated
not only by the rate of cell division but also by the
rate of cell loss. Although this seems a relatively
straightforward concept it was not until programmed
cell death (PCD or apoptosis) was described in 1972
by Kerr et al. (Kerr et al., 1972; 1994) that it was
generally appreciated that cell numbers and hence
physiological and pathological processes may be
affected by affecting the rate of cell loss as much as
by cell division. In the last two decades the
mechanisms and methods of induction of apoptosis
have been the subject of enormous research interest,
particularly the role of apoptotic mechanisms and
their malfunction in carcinogenesis.
Apoptosis and necrosis
Necrotic cell death represents an uncontrolled
destruction of the cell in response to an external
stimulus resulting in cellular anoxia and eventual
disruption of the plasma membrane with loss of cell
contents. By comparison, apoptosis is a controlled
active process which may be initiated from within the
cell or in response to a variety of extra-cellular
stimuli. Cellular components are systematically
broken down without disruption of the cell mem-
brane and the cell is divided up into membrane-
bound apoptotic bodies which are then phagocy-
tosed by neighbouring cells or macrophages. By
avoiding release of intracellular matter, the intense
peri-cellular inflammation associated with necrosis is
avoided, and cells may be removed from populations
TABLE I
SUMMARY OF DIFFERENCES BETWEEN APOPTOSIS AND NECROSIS
Apoptosis Necrosis
Occurrence
Initiating factors
Distribution
Mechamsm
Cytoplasmic changes
Nuclear changes
Effect on surrounding tissue
As part of physiological or pathological
processes
Range of extracellular and intracellular fac-
tors
Isolated apoptotic cells scattered widely
throughout tissues
A.cVvve process - ATP dependent-regulated
mechanism
Cytoplasmic shrinkage
Blebbing of cell membrane into apoptotic
bodies
Many organelles preserved and bound into
apoptotic bodies
Endonuclease activation, division of DNA
into oligosomal fragments
Chromatin condenses into specific 'crescents'
visible on light microscopy
Little
Always pathological
As a direct result of injury and cellular anoxia
Occur in groups/whole areas of tissue
Passive loss oi regulation
Swelling of cell membrane
Rupture of cell membrane with loss of
contents to extracellular space
Organelles lost
Random digestion of DNA
Chromatin flocculates
Intense inflammation
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without affecting adjacent tissue. The principal
differences between apoptosis and necrosis are
summarized in Table I.
Induction of apoptosis
It is a key feature of apoptosis that it may be
triggered by intracellular stimuli and hence provides
a means whereby a cell having recognized itself as
irreparably damaged may destroy itself; this is
termed 'deliberate cell suicide'. At the centre of
this process is the nucleoprotein product of the p53
gene which has been dubbed the 'guardian of the
genome' (Lane, 1992). In response to DNA damage
(e.g. by radiation or virus) p53 may lead to cell cycle
arrest to allow damaged DNA to be repaired, and if
repair is not possible, p53 may initiate apoptosis,
preventing the replication of abnormal genetic
material. p53 interacts with a complex family of
other nucleoproteins (e.g. Bax, BCL-2 andp2/), the
exact molecular mechanisms of apoptosis induction
remain the subject of intense research activity. It
follows that failure of normal p53 function may lead
to replication of cells with abnormal DNA and hence
to malignant transformation. At least half of all
malignant tumours are found to have abnormalities
of the p53 gene resulting in abnormal 'mutant' p53
(Carson and Lois, 1995). Gene therapy for neoplasia
relies on replacing mutant p53 genes with normal or
wild type genetic material to prevent further
replication of abnormal DNA.
Extra-cellular influences on apoptosis are not
necessarily dependent on p53. They include hormo-
nal influences such as growth hormone withdrawal
and the effects of drugs, notably chemotherapeutic
agents for cancer (vide infra).
Dexamethasone induces apoptosis in thymocytes
(Wyllie, 1980). and this is often used as a control in
studies of programmed cell-death. Apoptosis is
thought to be an important process in the reduction
of inflammatory cell numbers and resolution of
inflammatory processes (Haslett, 1992). In acute
asthma treated with corticosteroids the induction of
apoptotic cell death in eosinophils in sputum has
been observed to accompany resolution of the acute
attack (Woolley et al., 1996). Cytokines such as
GM-CSF and IL-5 which act as intercellular mes-
sengers have been found to prevent apoptosis in
eosinophils (Stern et al., 1992) and production of
these cytokines may be suppressed by steroids (Cox
et al., 1991). In addition, apoptosis is induced in the
inflammatory layer of human nasal polyps by in vitro
culture with dexamethasone (authors 1997, unpub-
lished data) and it is possible that this is one of the
mechanisms by which corticosteroid treatment leads
to regression of nasal polyps.
Apoptosis in non-malignant disease
Even in the developing embryo, apoptosis has a
fundamental role to play in tissue differentiation and
structural change. The re-absorption of interdigital
webs in utero is a widely quoted example of this.
Apoptosis has been demonstrated in the mouse
inner ear at an early stage of normal development
(Nishizaki et al., 1998) and abnormalities of apopto-
tic mechanisms may be implicated in the
pathogenesis of cleft palate.
Although apoptosis research is commonly asso-
ciated with the study of cancer and cancer therapy, it
is inevitable that such a fundamental biological
process will be implicated in some way in the
majority of human pathology.
Human disease may be associated with inhibition
of normal apoptosis, or an abnormal rise in apoptotic
rate (Thompson, 1995). Reduced lymphocyte sensi-
tivity to normal cell death signals has been
implicated in auto-immune disease (Mountz et al.,
1994). Viral infection may prevent cell suicide by the
expression of gene products such as BCL-2 which
mitigate against a cell's ability to induce apoptotic
death: a cell with normally functioning apoptotic
mechanisms might recognize the cellular and genetic
damage associated with viral infection, but by
preventing cell death from occurring, the virus
keeps the cell alive long enough for viral replication
to take place (Henderson et al., 1991).
Abnormally elevated rates of cell death have been
associated with degenerative diseases such as
Alzheimer's, heart failure and retinitis pigmentosa,
in which specific gene mutations lead to apoptosis of
photoreceptor cells. Loss of retinal cells may be
predisposed to by up to three completely separate
gene mutations.
There is particular interest in abnormal cell death
in human immunodeficiency virus (HIV) infection
and acquired immunodeficiency syndrome (AIDS)
(Gougeon and Montaigner, 1993). The immuno-
depletion of CD4 positive T cells that is a funda-
mental part of this disease is caused by programmed
cell death. Interestingly, it appears that infection
with the HIV virus can also lead to apoptosis in non-
infected T lymphocytes by interference with cell
surface signalling mechanisms.
Experimental evidence suggests that apoptotic cell
death in the labyrinth is responsible for several forms
of sensorineural deafness. Usami (Usami et al., 1997)
detected apoptosis in the cochlear hair cells of
senescence accelerated mice, hair cell apoptosis has
been detected after noise trauma (Nakagawa et al.,
1997) and aminoglycoside antibiotics have been
shown to induce apoptosis in hair cells in experi-
mental animals.
Measurement and identification of apoptosis
Identification of programmed cell death takes
advantage of the highly characteristic biochemical
and morphological changes that occur in the
apoptotic cell. These are summarized in Table II.
Some techniques are applicable only to single cell
suspensions, others may be used to identify cell
death in whole tissues such as sections of patho-
logical specimens.
Morphological identification
Electron microscopy represents the most reliable
method for qualitative identification, but to estimate
the proportion of cells undergoing apoptosis in a
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TABLE II
BIOCHEMICAL AND MORPHOLOGICAL FEATURES OF APOPTOSIS
Early/Biochemical Changes
Rise in intracellular calcium
Activation of endonuclease
DNA divided into 180 base pair fragments
(oligosomal fragments) '
Late/Nuclear Morphological Changes
Chromatin condenses
Nuclei pyknotic/small
hallmark 'crescents* visible in nucleus
Late/Cytoplasmic Morphological Changes
Cytoplasmic shrinkage away from neighbouring cells
Preservation of some organelles
Cell divides into membrane bound apoptotic bodies
Phagocytosis by neighbouring cells/macrophages
Applicable method of detection
Flow cytometery, gel electrophoresis (single suspension)
End labellingof 3-OH termino of oligosomal
(fragments-ISEL/TUNEL (single cells or tissue sections)
Conventional histological stains (whole sections)
Electron microscopy (single cells and whole sections)
Conventional histological stains (whole sections)
Electron microscopy (single cells and whole sections)
Acridine orange staining (single cell suspension)
section it is necessary to use high magnification
(X 100) light microscopy with a variety of staining
techniques. A disadvantage of morphological identi-
fication is that cells remain apparently normal to
inspection some while after the nuclear biochemical
events have started, so that biochemical techniques
of identification allows a greater and more repre-
sentative number of apoptotic cells to be identified.
Biochemical identification
After apoptosis is initiated, a calcium-dependent
endonuclease splits cellular DNA into fragments of
specific base pair length. These oligosomal fragments
are a biochemical hallmark of apoptosis and may be
identified by flow cytometry or by agarose gel
electrophoresis where a characteristic 'DNA ladder'
is obtained. These techniques are only possible with
single cell suspension, however, it is possible to label
the 3-OH terminal of the oligosomal fragment with a
labelled nucleotide which is then identified by
labelling with a secondary antibody. This in situ
(ISEL) or TdT mediated (TUNEL) end-labelling
may be used on sections of whole tissues to identify
areas of apoptosis and is hence of more use in clinical
research.
Apoptosis in head and neck cancer
Cancer cell death
The biggest challenge in modern oncology is the
removal of cancerous cells at the same time as
maintaining the normal cell population. Cells may be
lost from a tumour in three ways: necrosis, shedding
or apoptosis. Whilst some strategies, such as tumour
embolization, may induce necrosis, this is of neces-
sity a messy affair with local and systemic effects, and
is not tumour-specific. Inducing abnormal epithelial
cells to shed onto surfaces or into lumina where they
may no longer cause harm is an attractive idea, but
one unlikely to allow removal of any but the most
superficial layers of cells (Rew, 1993). This leaves us
with apoptosis, or programmed cell death. Even
'mitotic cell death', the title given to the cell arrest
seen with radiotherapy and some forms of che-
motherapy, ultimately, leads to apoptosis (Joiner,
1993), whilst this induction is more direct with most
chemotherapy, such as cisplatinum. Hence, an
understanding of apoptosis in head and neck cancer
is vital to the development of more effective, and less
toxic, therapies.
Apoptosis in the development of cancer
There is some evidence that apoptosis is disor-
dered in pre-malignant tissues of the head and neck.
As one progresses from normal, through dysplastic
to frankly malignant oral epithelium, apoptosis fails
to rise in proportion to mitosis (Birchall et al., 1995)
(Figure 1). There is also a topographic switching of
mitosis and apoptosis in premalignant epithelium,
with peak apoptosis moving more superficially and
peak mitosis moving to the basal layer (Birchall
et al., 1996). These two events are likely to lead to a
loss of normal policing of aberrant cells, particularly
in the basal, putative stem-cell, layer where muta-
tions are most likely to have an impact on the
eventual development of invasive disease. The
underlying molecular events presaging malignancy
are unclear, but there appears to be a paradoxical
fall in expression of bcl-2, a key gene in the cellular
control of apoptosis, in premalignant and malignant
epithelia of the head and neck (Birchall et al, 1997).
The importance of pinning down the defects in
apoptosis present in pre-malignant tissue lies in the
I A. I.
IM.I.
FIG. 1
Apoptotic and mitotic indices for oral epithelium.
Apoptotic (Al) and Mitotic (MI) indices for oral epithelium.
N = normal, H = hyperplasia, D = dysplasia, C = invasive
carcinoma. HN = normal tissue from people with hyperplasia,
DN = normal tissue from people with dysplasia, CN = normal
tissue from people with invasive carcinoma.
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development of effective strategies for preventing
the occurrence of metachronous cancers, a particular
problem in head and neck cancer (Jones et al., 1995).
Apoptosis in untreated tumours
Studies of the difference between actual and
potential doubling time of tumours (Tpot) (Wilson,
1991), show that more than 90 per cent of active
tumour cells must survive for only a brief time before
dying, probably of apoptosis. The measurement of
apoptosis in tumours in vivo, however, is far from
straightforward. Direct counts of apoptotic cells in
tumour sections give a reasonable intra-tumour
variability, but there is a long learning curve and
this process is very laborious, even with image-
analysis. The use of end-labelling techniques
(Wijsman et al., 1993) to stain apoptotic cells has
been questioned, and it has been demonstrated that,
for head and neck cancer, it was a less accurate
method than simple counts (Saunders, 1997, unpub-
lished data). Provided it is possible to verify light
microscopic observations with electron microscope
appearances this should remain the gold standard,
and recent advances in histological techniques have
simplified matters (Amal et al., 1998). However,
recent confirmation of impressive morphological
diversity within programmed cell death, which has
been hitherto described in terms of the stereotyped
features seen in cells of lymphoid lineage threatens
even this method of measurement (Amin and
Bowen, 1997).
Another complication is the presence of tumour-
infiltrating lymphocytes. These too may undergo
apoptosis, and the differentiation between separate
cell lines undergoing apoptosis can be difficult. In
fact, this phenomenon is important in itself: squa-
mous carcinoma can induce apoptosis in white cells,
and this may be a potent means by which tumours
escape the immune surveillance that might otherwise
clean them out (O'Mahony et al., 1993).
Measuring head and neck cancer cell line apopto-
sis in vitro is a simpler matter, and is usually done in
a number of ways in every experiment to increase
validity. Typically, morphological counts will be
performed along with tests of dye uptake (acridine
orange) and DNA laddering (Sarraf and Bowen,
1986). However, even here, observations of more
than one type of programmed cell death have
recently been made on a tongue squamous cell
carcinoma line (Amal A., personal communication).
Each type of apoptosis may require different triggers
and have separate sub-cellular mechanisms (Clarke,
1990). Thus, much work remains to be done to
unravel the normal patterns of apoptosis in head and
neck tumours, both at the cellular and sub-cellular
levels, before we can begin to understand what
makes a tumour cell kill itself, and therefore how we
may persuade more to do so.
The control of apoptosis in squamous carcinoma
cells is known to be disordered. The most consistent
gene-alteration seen in head and neck cancer is that
of the p53 gene. Normally, this promotes apoptosis
in response to various stimuli, and may be regarded
as the cellular 'policeman'. It is involved in a
reciprocal arrangement with dimers of the bcl-2
family, the resolution of which determines whether a
cell commits suicide (Raff, 1992). Thus, an aberrant
p53 gene will tip the balance in the favour of cell
survival, even in the presence of a disordered
genome, with progression of cancer the likely result.
There are many other genes and gene products
involved in the apoptosis pathway, which is becom-
ing increasingly complex. Many of them have
identified abnormalities in head and neck cancer
(Ogden et al., 1992), and are therefore potential
therapeutic targets.
Apoptosis as a result of therapy
Whenever we touch a tumour, be it with knives,
radiation or drugs, we alter its biological behaviour.
Again, this may be measured in terms of an increase
in Tpot (Wilson, 1991). Unfortunately, the result, for
example after open biopsy or recurrence after
radiotherapy, may be a more aggressive tumour.
Conversely, however, the main mode of action of the
main chemotherapeutic agents used against head
and neck cancer seems to be via apoptosis, and it is
likely that mitotic cell death after radiotherapy is
ultimately along apoptotic pathways. Nonetheless,
these strategies are blunderbuss ones, causing death
(by apoptosis, necrosis, or simple excision) of many
normal cells necessary for the maintenance of local
and systemic functional integrity.
What is required is a better directed means of
apoptosis-induction in tumour cells. A number of
approaches to this are currently being explored,
particularly via gene therapy. One strategy is to
insert copies of normal p53 into tumours where
aberrant expression has been detected. This may be
achieved using an adenovirus vector, and has been
shown to cause regression of tumours in vivo
(dayman et al., 1996). However, the effects seem
to be short-lived, and complete regression in man
has not been seen. An alternative form of gene
therapy is to try and stimulate local immune cells to
recognize and kill tumour cells in vitro and then
return them to the circulation. This is a reasonable
route where one can identify a definite target
antigen, such as that for EBV in EBV-related
nasopharyngeal carcinoma, but is less practical for
most squamous cancer (R. Hawkins, personal com-
munication). An alternative to gene therapy is the
activation of tumour-cell receptors that initiate
apoptosis, particularly via the growth factor recep-
tor-tyrosine kinase cascade. This is currently being
pursued in a number of centres world-wide, with
several agents in phase I 'trials in head and neck
cancer patients (e.g. Bier et al., 1995).
Conclusions
Apoptosis and cell death is as fundamental a part
of life as mitosis and cell division. It is a key process
in development and also a way in which abnormal
and effete cells can be removed from the host before
they cause problems.
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Such an important part of normal cellular activity
is inevitably implicated in many pathological condi-
tions, and it is only in recent years that it has become
apparent by how much. The implication of under-
standing and hence being able to influence this
process is enormous: if we wish to kill tumours, we
need to know what makes them die. Most head and
neck cancer cells die via apoptosis and this is a
highly-controlled process with consequent potential
for manipulation. Therefore, research into types and
mechanisms of apoptosis of head and neck cancer
cells is a vital pre-requisite to the development of
tomorrow's effective therapies for the victims of this,
in many ways the most devastating of cancers.
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